Home > News > pSivida receives patent for BioSilicon pills
July 26th, 2004
pSivida receives patent for BioSilicon pills
Abstract:
pSivida Limited (PSD) announced that its UK subsidiary has been granted a further Australian patent for BioSiliconTM. The patent relates to the invention of orally administrable pharmaceutical products that comprise porous and/or polycrystalline BioSilicon.
Source:
egoli
Related News Press |
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||